Actinium Pharmaceuticals, Inc. — Form D
Actinium Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-08. Industry: Pharmaceuticals.
Offering
- Filed: 2013-10-08
- Form: D
- Accession: 0001213900-13-005605
- Industry: Pharmaceuticals
- Exemptions: 06b
- Investors: 25
- Date of first sale: 2013-09-25
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-204170
Issuer
- Name: Actinium Pharmaceuticals, Inc.
- CIK: 0001388320
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 501 FIFTH AVENUE, NEW YORK, NY, 10017
- Phone: (646)459-4201
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Dragan J Cicic | Executive Officer | New York, NY |
| David J Nicholson | Director | New York, NY |
| Sergio J Traversa | Director | New York, NY |
| Sergio J Traversa | Executive Officer | New York, NY |
| Kaushik J Dave | Director | New York, NY |
| Kaushik J Dave | Executive Officer | New York, NY |
| Sandesh J Seth | Director | New York, NY |
| Richard I Steinhart | Director | New York, NY |
| Sergio V Traversa | Director | New York, NY |
| Sergio V Traversa | Executive Officer | New York, NY |
| Jack V Talley | Director | New York, NY |
| Jack V Talley | Executive Officer | New York, NY |
Other filings by this issuer (5)
More